ERIN MCDONOUGH: Open Payments
NPI 1073964268 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,571 in 132 payments from 44 companies in 2025. Trend: 2023 $3,171 · 2024 $3,164 · 2025 $3,571
Food & beverage: $3,571
| Company | Payments | Amount |
|---|---|---|
| Rigel Pharmaceuticals, Inc. | 3 | $355 |
| PFIZER INC. | 11 | $268 |
| AstraZeneca Pharmaceuticals LP | 8 | $217 |
| Novartis Pharmaceuticals Corporation | 10 | $208 |
| Janssen Biotech, Inc. | 8 | $187 |
| GlaxoSmithKline, LLC. | 6 | $166 |
| ABBVIE INC. | 6 | $159 |
| Incyte Corporation | 7 | $153 |
| Blueprint Medicines Corporation | 3 | $150 |
| Regeneron Healthcare Solutions, Inc. | 5 | $139 |
Products named: TAVALISSE, AYVAKIT, OJJAARA, LIBTAYO, REBLOZYL, IBRANCE, Padcev, CARVYKTI.
Industry payments across FL — which companies pay providers there.
